CIK 0001314102
- Non-accelerated filer
- Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262774444
- Phone
- +1 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-06-21 | Mazzo David J Director | Exercise or conversion · Deferred Stock Units | −8,333 | 0 | ||
| 2019-06-21 | Peterson Kristine Director | Exercise or conversion | +6,667 | 6,667 | ||
| 2019-06-21 | Peterson Kristine Director | Exercise or conversion · Deferred Stock Units | −6,667 | 0 | ||
| 2019-06-21 | Godshall Douglas Evan Director | Exercise or conversion | +6,667 | 36,167 | ||
| 2019-06-21 | Godshall Douglas Evan Director | Exercise or conversion · Deferred Stock Units | −6,667 | 0 | ||
| 2019-06-21 | Duker Jay S. Director | Exercise or conversion | +6,667 | 44,167 | ||
| 2019-06-21 | Duker Jay S. Director | Exercise or conversion · Deferred Stock Units | −6,667 | 0 | ||
| 2019-06-14 | Lurker Nancy President & CEO | Exercise or conversion | +45,000 | 285,200 | ||
| 2019-06-14 | Lurker Nancy President & CEO | Exercise or conversion · Restricted Stock Units | −45,000 | 90,000 | ||
| 2019-06-14 | Ross Leonard S | Exercise or conversion | +8,280 | 87,732 | ||
| 2019-06-14 | Ross Leonard S | Shares withheld for taxes | −2,394 | $1.53 | $4K | 85,338 |
| 2019-06-14 | Ross Leonard S | Exercise or conversion · Restricted Stock Units | −8,280 | 16,560 | ||
| 2019-06-14 | Paggiarino Dario A. Chief Medical Officer | Exercise or conversion | +14,200 | 42,612 | ||
| 2019-06-14 | Paggiarino Dario A. Chief Medical Officer | Shares withheld for taxes | −4,175 | $1.53 | $6K | 38,437 |
| 2019-06-14 | Paggiarino Dario A. Chief Medical Officer | Exercise or conversion · Restricted Stock Units | −14,200 | 28,400 | ||
| 2019-06-10 | Jones David Scott SVP & Chief Commercial Officer | Grant or award · Stock Options (Right to buy) | +350,000 | 350,000 | ||
| 2019-05-13 | Landis John B. Director | Purchase | +40,000 | $1.74 | $70K | 40,000 |
| 2019-04-12 | Duker Jay S. Director | Exercise or conversion | +20,000 | $1.77 | $35K | 37,500 |
| 2019-04-12 | Duker Jay S. Director | Exercise or conversion · Stock Option (Right to Buy) | −20,000 | 0 | ||
| 2019-04-01 | Duker Jay S. Director | Purchase | +5,000 | $1.89 | $9K | 17,500 |
Page 36 of 40 · 795 trades